Global Quadrivalent Meningococcal Vaccine Market Research Report 2026(Status and Outlook)
The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.
The global Quadrivalent Meningococcal Vaccine market size was estimated at USD 183.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Quadrivalent Meningococcal Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Quadrivalent Meningococcal Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Quadrivalent Meningococcal Vaccine market.
Global Quadrivalent Meningococcal Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi-Pasteur
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
Market Segmentation (by Type)
Polysaccharide Vaccine
Conjugate Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Quadrivalent Meningococcal Vaccine Market
Overview of the regional outlook of the Quadrivalent Meningococcal Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Quadrivalent Meningococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Quadrivalent Meningococcal Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Quadrivalent Meningococcal Vaccine market size was estimated at USD 183.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Quadrivalent Meningococcal Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Quadrivalent Meningococcal Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Quadrivalent Meningococcal Vaccine market.
Global Quadrivalent Meningococcal Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi-Pasteur
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
Market Segmentation (by Type)
Polysaccharide Vaccine
Conjugate Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Quadrivalent Meningococcal Vaccine Market
Overview of the regional outlook of the Quadrivalent Meningococcal Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Quadrivalent Meningococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Quadrivalent Meningococcal Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Quadrivalent Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Quadrivalent Meningococcal Vaccine Segment by Type
1.2.2 Quadrivalent Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Quadrivalent Meningococcal Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Quadrivalent Meningococcal Vaccine Product Life Cycle
3.3 Global Quadrivalent Meningococcal Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Quadrivalent Meningococcal Vaccine Market Competitive Situation and Trends
3.8.1 Quadrivalent Meningococcal Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Quadrivalent Meningococcal Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 QUADRIVALENT MENINGOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Quadrivalent Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF QUADRIVALENT MENINGOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Quadrivalent Meningococcal Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Quadrivalent Meningococcal Vaccine Market
5.7 ESG Ratings of Leading Companies
6 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Quadrivalent Meningococcal Vaccine Market Size by Type (2020-2025)
6.4 Global Quadrivalent Meningococcal Vaccine Price by Type (2020-2025)
7 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Quadrivalent Meningococcal Vaccine Market Sales by Application (2020-2025)
7.3 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
8 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SALES BY REGION
8.1 Global Quadrivalent Meningococcal Vaccine Sales by Region
8.1.1 Global Quadrivalent Meningococcal Vaccine Sales by Region
8.1.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region
8.2 Global Quadrivalent Meningococcal Vaccine Market Size by Region
8.2.1 Global Quadrivalent Meningococcal Vaccine Market Size by Region
8.2.2 Global Quadrivalent Meningococcal Vaccine Market Size by Region
8.3 North America
8.3.1 North America Quadrivalent Meningococcal Vaccine Sales by Country
8.3.2 North America Quadrivalent Meningococcal Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Quadrivalent Meningococcal Vaccine Sales by Country
8.4.2 Europe Quadrivalent Meningococcal Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region
8.5.2 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Quadrivalent Meningococcal Vaccine Sales by Country
8.6.2 South America Quadrivalent Meningococcal Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Region
8.7.2 Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Quadrivalent Meningococcal Vaccine by Region(2020-2025)
9.2 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Quadrivalent Meningococcal Vaccine Production
9.4.1 North America Quadrivalent Meningococcal Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Quadrivalent Meningococcal Vaccine Production
9.5.1 Europe Quadrivalent Meningococcal Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Quadrivalent Meningococcal Vaccine Production (2020-2025)
9.6.1 Japan Quadrivalent Meningococcal Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Quadrivalent Meningococcal Vaccine Production (2020-2025)
9.7.1 China Quadrivalent Meningococcal Vaccine Production Growth Rate (2020-2025)
9.7.2 China Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi-Pasteur
10.1.1 Sanofi-Pasteur Basic Information
10.1.2 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Overview
10.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Market Performance
10.1.4 Sanofi-Pasteur Business Overview
10.1.5 Sanofi-Pasteur SWOT Analysis
10.1.6 Sanofi-Pasteur Recent Developments
10.2 Walvax
10.2.1 Walvax Basic Information
10.2.2 Walvax Quadrivalent Meningococcal Vaccine Product Overview
10.2.3 Walvax Quadrivalent Meningococcal Vaccine Product Market Performance
10.2.4 Walvax Business Overview
10.2.5 Walvax SWOT Analysis
10.2.6 Walvax Recent Developments
10.3 Chengdu Kanghua Biological Products Co., Ltd.
10.3.1 Chengdu Kanghua Biological Products Co., Ltd. Basic Information
10.3.2 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.3.4 Chengdu Kanghua Biological Products Co., Ltd. Business Overview
10.3.5 Chengdu Kanghua Biological Products Co., Ltd. SWOT Analysis
10.3.6 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
10.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information
10.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
10.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments
10.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
10.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information
10.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
10.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments
10.6 Beijing Institute of Biological Products Co., Ltd.
10.6.1 Beijing Institute of Biological Products Co., Ltd. Basic Information
10.6.2 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.6.4 Beijing Institute of Biological Products Co., Ltd. Business Overview
10.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments
10.7 CanSino Biological Co., Ltd.
10.7.1 CanSino Biological Co., Ltd. Basic Information
10.7.2 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.7.4 CanSino Biological Co., Ltd. Business Overview
10.7.5 CanSino Biological Co., Ltd. Recent Developments
10.8 Hualan Biological Vaccine Co., Ltd.
10.8.1 Hualan Biological Vaccine Co., Ltd. Basic Information
10.8.2 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.8.4 Hualan Biological Vaccine Co., Ltd. Business Overview
10.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments
10.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
10.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information
10.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
10.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments
11 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET FORECAST BY REGION
11.1 Global Quadrivalent Meningococcal Vaccine Market Size Forecast
11.2 Global Quadrivalent Meningococcal Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Quadrivalent Meningococcal Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Forecast by Region
11.2.4 South America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Quadrivalent Meningococcal Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Quadrivalent Meningococcal Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Quadrivalent Meningococcal Vaccine by Type (2026-2035)
12.1.2 Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Quadrivalent Meningococcal Vaccine by Type (2026-2035)
12.2 Global Quadrivalent Meningococcal Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Quadrivalent Meningococcal Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Quadrivalent Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Quadrivalent Meningococcal Vaccine Segment by Type
1.2.2 Quadrivalent Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Quadrivalent Meningococcal Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Quadrivalent Meningococcal Vaccine Product Life Cycle
3.3 Global Quadrivalent Meningococcal Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Quadrivalent Meningococcal Vaccine Market Competitive Situation and Trends
3.8.1 Quadrivalent Meningococcal Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Quadrivalent Meningococcal Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 QUADRIVALENT MENINGOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Quadrivalent Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF QUADRIVALENT MENINGOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Quadrivalent Meningococcal Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Quadrivalent Meningococcal Vaccine Market
5.7 ESG Ratings of Leading Companies
6 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Quadrivalent Meningococcal Vaccine Market Size by Type (2020-2025)
6.4 Global Quadrivalent Meningococcal Vaccine Price by Type (2020-2025)
7 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Quadrivalent Meningococcal Vaccine Market Sales by Application (2020-2025)
7.3 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
8 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SALES BY REGION
8.1 Global Quadrivalent Meningococcal Vaccine Sales by Region
8.1.1 Global Quadrivalent Meningococcal Vaccine Sales by Region
8.1.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region
8.2 Global Quadrivalent Meningococcal Vaccine Market Size by Region
8.2.1 Global Quadrivalent Meningococcal Vaccine Market Size by Region
8.2.2 Global Quadrivalent Meningococcal Vaccine Market Size by Region
8.3 North America
8.3.1 North America Quadrivalent Meningococcal Vaccine Sales by Country
8.3.2 North America Quadrivalent Meningococcal Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Quadrivalent Meningococcal Vaccine Sales by Country
8.4.2 Europe Quadrivalent Meningococcal Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region
8.5.2 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Quadrivalent Meningococcal Vaccine Sales by Country
8.6.2 South America Quadrivalent Meningococcal Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Region
8.7.2 Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Quadrivalent Meningococcal Vaccine by Region(2020-2025)
9.2 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Quadrivalent Meningococcal Vaccine Production
9.4.1 North America Quadrivalent Meningococcal Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Quadrivalent Meningococcal Vaccine Production
9.5.1 Europe Quadrivalent Meningococcal Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Quadrivalent Meningococcal Vaccine Production (2020-2025)
9.6.1 Japan Quadrivalent Meningococcal Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Quadrivalent Meningococcal Vaccine Production (2020-2025)
9.7.1 China Quadrivalent Meningococcal Vaccine Production Growth Rate (2020-2025)
9.7.2 China Quadrivalent Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi-Pasteur
10.1.1 Sanofi-Pasteur Basic Information
10.1.2 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Overview
10.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Market Performance
10.1.4 Sanofi-Pasteur Business Overview
10.1.5 Sanofi-Pasteur SWOT Analysis
10.1.6 Sanofi-Pasteur Recent Developments
10.2 Walvax
10.2.1 Walvax Basic Information
10.2.2 Walvax Quadrivalent Meningococcal Vaccine Product Overview
10.2.3 Walvax Quadrivalent Meningococcal Vaccine Product Market Performance
10.2.4 Walvax Business Overview
10.2.5 Walvax SWOT Analysis
10.2.6 Walvax Recent Developments
10.3 Chengdu Kanghua Biological Products Co., Ltd.
10.3.1 Chengdu Kanghua Biological Products Co., Ltd. Basic Information
10.3.2 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.3.4 Chengdu Kanghua Biological Products Co., Ltd. Business Overview
10.3.5 Chengdu Kanghua Biological Products Co., Ltd. SWOT Analysis
10.3.6 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
10.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information
10.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
10.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments
10.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
10.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information
10.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
10.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments
10.6 Beijing Institute of Biological Products Co., Ltd.
10.6.1 Beijing Institute of Biological Products Co., Ltd. Basic Information
10.6.2 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.6.4 Beijing Institute of Biological Products Co., Ltd. Business Overview
10.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments
10.7 CanSino Biological Co., Ltd.
10.7.1 CanSino Biological Co., Ltd. Basic Information
10.7.2 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.7.4 CanSino Biological Co., Ltd. Business Overview
10.7.5 CanSino Biological Co., Ltd. Recent Developments
10.8 Hualan Biological Vaccine Co., Ltd.
10.8.1 Hualan Biological Vaccine Co., Ltd. Basic Information
10.8.2 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.8.4 Hualan Biological Vaccine Co., Ltd. Business Overview
10.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments
10.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
10.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information
10.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
10.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
10.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
10.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments
11 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET FORECAST BY REGION
11.1 Global Quadrivalent Meningococcal Vaccine Market Size Forecast
11.2 Global Quadrivalent Meningococcal Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Quadrivalent Meningococcal Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Forecast by Region
11.2.4 South America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Quadrivalent Meningococcal Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Quadrivalent Meningococcal Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Quadrivalent Meningococcal Vaccine by Type (2026-2035)
12.1.2 Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Quadrivalent Meningococcal Vaccine by Type (2026-2035)
12.2 Global Quadrivalent Meningococcal Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Quadrivalent Meningococcal Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Quadrivalent Meningococcal Vaccine Market Size by Type (M USD)
Table 4. Global Quadrivalent Meningococcal Vaccine Market Size by Application
Table 5. Quadrivalent Meningococcal Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Quadrivalent Meningococcal Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Quadrivalent Meningococcal Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Meningococcal Vaccine as of 2025)
Table 11. Global Market Quadrivalent Meningococcal Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Quadrivalent Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Quadrivalent Meningococcal Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Quadrivalent Meningococcal Vaccine Sales by Type (K MT)
Table 27. Global Quadrivalent Meningococcal Vaccine Market Size by Type (M USD)
Table 28. Global Quadrivalent Meningococcal Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Quadrivalent Meningococcal Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Quadrivalent Meningococcal Vaccine Market Share by Type (2020-2025)
Table 32. Global Quadrivalent Meningococcal Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Quadrivalent Meningococcal Vaccine Sales (K MT) by Application
Table 34. Global Quadrivalent Meningococcal Vaccine Market Size by Application
Table 35. Global Quadrivalent Meningococcal Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Quadrivalent Meningococcal Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Quadrivalent Meningococcal Vaccine Market Share by Application (2020-2025)
Table 39. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Quadrivalent Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025)
Table 44. North America Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Quadrivalent Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Quadrivalent Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Quadrivalent Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Quadrivalent Meningococcal Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi-Pasteur Basic Information
Table 63. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Overview
Table 64. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi-Pasteur Business Overview
Table 66. Sanofi-Pasteur SWOT Analysis
Table 67. Sanofi-Pasteur Recent Developments
Table 68. Walvax Basic Information
Table 69. Walvax Quadrivalent Meningococcal Vaccine Product Overview
Table 70. Walvax Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Walvax Business Overview
Table 72. Walvax SWOT Analysis
Table 73. Walvax Recent Developments
Table 74. Chengdu Kanghua Biological Products Co., Ltd. Basic Information
Table 75. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 76. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Chengdu Kanghua Biological Products Co., Ltd. Business Overview
Table 78. Chengdu Kanghua Biological Products Co., Ltd. SWOT Analysis
Table 79. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
Table 80. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information
Table 81. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 82. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
Table 84. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments
Table 85. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information
Table 86. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 87. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
Table 89. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments
Table 90. Beijing Institute of Biological Products Co., Ltd. Basic Information
Table 91. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 92. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Beijing Institute of Biological Products Co., Ltd. Business Overview
Table 94. Beijing Institute of Biological Products Co., Ltd. Recent Developments
Table 95. CanSino Biological Co., Ltd. Basic Information
Table 96. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 97. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CanSino Biological Co., Ltd. Business Overview
Table 99. CanSino Biological Co., Ltd. Recent Developments
Table 100. Hualan Biological Vaccine Co., Ltd. Basic Information
Table 101. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 102. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Hualan Biological Vaccine Co., Ltd. Business Overview
Table 104. Hualan Biological Vaccine Co., Ltd. Recent Developments
Table 105. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information
Table 106. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 107. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
Table 109. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments
Table 110. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Quadrivalent Meningococcal Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Quadrivalent Meningococcal Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Quadrivalent Meningococcal Vaccine Market Size by Type (M USD)
Table 4. Global Quadrivalent Meningococcal Vaccine Market Size by Application
Table 5. Quadrivalent Meningococcal Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Quadrivalent Meningococcal Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Quadrivalent Meningococcal Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Meningococcal Vaccine as of 2025)
Table 11. Global Market Quadrivalent Meningococcal Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Quadrivalent Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Quadrivalent Meningococcal Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Quadrivalent Meningococcal Vaccine Sales by Type (K MT)
Table 27. Global Quadrivalent Meningococcal Vaccine Market Size by Type (M USD)
Table 28. Global Quadrivalent Meningococcal Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Quadrivalent Meningococcal Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Quadrivalent Meningococcal Vaccine Market Share by Type (2020-2025)
Table 32. Global Quadrivalent Meningococcal Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Quadrivalent Meningococcal Vaccine Sales (K MT) by Application
Table 34. Global Quadrivalent Meningococcal Vaccine Market Size by Application
Table 35. Global Quadrivalent Meningococcal Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Quadrivalent Meningococcal Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Quadrivalent Meningococcal Vaccine Market Share by Application (2020-2025)
Table 39. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Quadrivalent Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025)
Table 44. North America Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Quadrivalent Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Quadrivalent Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Quadrivalent Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Quadrivalent Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Quadrivalent Meningococcal Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Quadrivalent Meningococcal Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Quadrivalent Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi-Pasteur Basic Information
Table 63. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Overview
Table 64. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi-Pasteur Business Overview
Table 66. Sanofi-Pasteur SWOT Analysis
Table 67. Sanofi-Pasteur Recent Developments
Table 68. Walvax Basic Information
Table 69. Walvax Quadrivalent Meningococcal Vaccine Product Overview
Table 70. Walvax Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Walvax Business Overview
Table 72. Walvax SWOT Analysis
Table 73. Walvax Recent Developments
Table 74. Chengdu Kanghua Biological Products Co., Ltd. Basic Information
Table 75. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 76. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Chengdu Kanghua Biological Products Co., Ltd. Business Overview
Table 78. Chengdu Kanghua Biological Products Co., Ltd. SWOT Analysis
Table 79. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
Table 80. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information
Table 81. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 82. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
Table 84. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments
Table 85. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information
Table 86. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 87. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
Table 89. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments
Table 90. Beijing Institute of Biological Products Co., Ltd. Basic Information
Table 91. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 92. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Beijing Institute of Biological Products Co., Ltd. Business Overview
Table 94. Beijing Institute of Biological Products Co., Ltd. Recent Developments
Table 95. CanSino Biological Co., Ltd. Basic Information
Table 96. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 97. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CanSino Biological Co., Ltd. Business Overview
Table 99. CanSino Biological Co., Ltd. Recent Developments
Table 100. Hualan Biological Vaccine Co., Ltd. Basic Information
Table 101. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 102. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Hualan Biological Vaccine Co., Ltd. Business Overview
Table 104. Hualan Biological Vaccine Co., Ltd. Recent Developments
Table 105. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information
Table 106. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 107. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
Table 109. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments
Table 110. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Quadrivalent Meningococcal Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Quadrivalent Meningococcal Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Quadrivalent Meningococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Quadrivalent Meningococcal Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Quadrivalent Meningococcal Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Quadrivalent Meningococcal Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Quadrivalent Meningococcal Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Quadrivalent Meningococcal Vaccine Product Life Cycle
Figure 13. Quadrivalent Meningococcal Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Quadrivalent Meningococcal Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Quadrivalent Meningococcal Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Quadrivalent Meningococcal Vaccine
Figure 19. Global Quadrivalent Meningococcal Vaccine Market PEST Analysis
Figure 20. Global Quadrivalent Meningococcal Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Quadrivalent Meningococcal Vaccine Market Share by Type
Figure 27. Sales Market Share of Quadrivalent Meningococcal Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Quadrivalent Meningococcal Vaccine by Type in 2025
Figure 29. Market Share of Quadrivalent Meningococcal Vaccine by Type (2020-2025)
Figure 30. Market Share of Quadrivalent Meningococcal Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Quadrivalent Meningococcal Vaccine Market Share by Application
Figure 33. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application in 2025
Figure 35. Global Quadrivalent Meningococcal Vaccine Market Share by Application (2020-2025)
Figure 36. Global Quadrivalent Meningococcal Vaccine Market Share by Application in 2025
Figure 37. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025)
Figure 40. North America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 43. North America Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Quadrivalent Meningococcal Vaccine Market Size by Country in 2024
Figure 45. U.S. Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Quadrivalent Meningococcal Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Quadrivalent Meningococcal Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Quadrivalent Meningococcal Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Quadrivalent Meningococcal Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Quadrivalent Meningococcal Vaccine Market Size by Country in 2024
Figure 55. Germany Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Quadrivalent Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Quadrivalent Meningococcal Vaccine Market Size by Region in 2024
Figure 68. China Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 80. South America Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Quadrivalent Meningococcal Vaccine Market Size by Country in 2024
Figure 82. Brazil Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Quadrivalent Meningococcal Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Quadrivalent Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Quadrivalent Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Quadrivalent Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Quadrivalent Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Quadrivalent Meningococcal Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Quadrivalent Meningococcal Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Quadrivalent Meningococcal Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Quadrivalent Meningococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Quadrivalent Meningococcal Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Quadrivalent Meningococcal Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Quadrivalent Meningococcal Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Quadrivalent Meningococcal Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Quadrivalent Meningococcal Vaccine Product Life Cycle
Figure 13. Quadrivalent Meningococcal Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Quadrivalent Meningococcal Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Quadrivalent Meningococcal Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Quadrivalent Meningococcal Vaccine
Figure 19. Global Quadrivalent Meningococcal Vaccine Market PEST Analysis
Figure 20. Global Quadrivalent Meningococcal Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Quadrivalent Meningococcal Vaccine Market Share by Type
Figure 27. Sales Market Share of Quadrivalent Meningococcal Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Quadrivalent Meningococcal Vaccine by Type in 2025
Figure 29. Market Share of Quadrivalent Meningococcal Vaccine by Type (2020-2025)
Figure 30. Market Share of Quadrivalent Meningococcal Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Quadrivalent Meningococcal Vaccine Market Share by Application
Figure 33. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application in 2025
Figure 35. Global Quadrivalent Meningococcal Vaccine Market Share by Application (2020-2025)
Figure 36. Global Quadrivalent Meningococcal Vaccine Market Share by Application in 2025
Figure 37. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Quadrivalent Meningococcal Vaccine Market Size by Region (2020-2025)
Figure 40. North America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 43. North America Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Quadrivalent Meningococcal Vaccine Market Size by Country in 2024
Figure 45. U.S. Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Quadrivalent Meningococcal Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Quadrivalent Meningococcal Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Quadrivalent Meningococcal Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Quadrivalent Meningococcal Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Quadrivalent Meningococcal Vaccine Market Size by Country in 2024
Figure 55. Germany Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Quadrivalent Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Quadrivalent Meningococcal Vaccine Market Size by Region in 2024
Figure 68. China Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 80. South America Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Quadrivalent Meningococcal Vaccine Market Size by Country in 2024
Figure 82. Brazil Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Quadrivalent Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Quadrivalent Meningococcal Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Quadrivalent Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Quadrivalent Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Quadrivalent Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Quadrivalent Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Quadrivalent Meningococcal Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Quadrivalent Meningococcal Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Quadrivalent Meningococcal Vaccine Market Share Forecast by Application (2026-2035)
